Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

H.R. 1908 Patent Reform Act of 2007
S. 1145 Patent Reform Act of 2007

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007
H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007
H.R. 4854 False Claims Act Correction Act of 2007
S. 2029 False Claims Act Correction Act of 2007
H.R. 4703 Vaccine Shortage Preparedness Act of 2008
S. 2467 Vaccine Shortage Preparedness Act of 2008
S. 2476 Improved Vaccines Supply Act
H.R. 3944 National Hepatitis B Act
H.R. 5884 Sunshine in Litigation Act of 2008
S. 2449 Sunshine in Litigation Act of 2007
H.R. 5605 Physician Payments Sunshine Act of 2008
S. 2029 Physician Payments Sunshine Act of 2007
H.R. 3610 Food and Drug Import Safety Act of 2007

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

S. 623 Access to Lifesaving Medicine Act
H.R. 1038 Access to Lifesaving Medicine Act
H.R. 1956 Patient Protection and Innovative Biologic Medicine Act of 2007
S. 1695 Biologics Price Competition and Innovation Act of 2007
S. 1505 Affordable Biologics for Consumer Act

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 4 Medicare Prescription Drug Price Negotiation Act of 2007
S. 3 Medicare Prescription Drug Price Negotiation Act of 2007
H.R. 3162 Children's Health and Medicare Protection Act of 2007
S. 1224 SCHIP Reauthorization Act of 2007
S. 2532 Medicare, Medicaid, and SCHIP Indian Health Care Improvement Act of 2007
S. 2086 SCHIP Extension Act of 2007
H.R. 3176 SCHIP Reauthorization and Reform Act of 2007
H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008
S. 3101 Medicare Improvements for Patients and Providers Act of 2008
H.R. 3043 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008 - pertaining to AIDS & HIV treatments

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

H.R. 2138 Investment in America Act of 2007 - to extend the R&D tax credit.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TRD

16. Specific lobbying issues

U.S. Korea Free Trade Agreement - provisions pertaining to the protection of intellectual property
U.S. Panama Free Tree Agreement - provisions pertaining to the protection of intellectual property
H.R. 3688 - U.S. Peru Free Trade Agreement - provisions pertaining to the protection of intellectual property
U.S. Columbia Free Trade Agreement - provisions pertaining to the protection of intellectual property
H.R. 3866 Small Business Programs Act of 2007

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization